$TRXDW
Stock $trxdw

$trxdw Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-K Financial Statement

#000143774922004657 Filed on February 28, 2022

Income Statement

Concept	2021 Q4	2021	2020 Q4
Revenue	$2.476M	$8.232M	$1.107M
YoY Change	123.67%	159.28%	61.14%
Cost Of Revenue	$2.287M	$11.10M	$593.0K
YoY Change	285.67%	114.79%	-94.55%
Gross Profit	$189.0K	-$2.864M	$514.0K
YoY Change	-63.23%	43.85%	-105.04%
Gross Profit Margin	7.63%	-34.79%	46.43%
Selling, General & Admin	$9.155M	$32.72M	$6.484M
YoY Change	41.19%	20.28%	-30.93%
% of Gross Profit	4843.92%		1261.48%
Research & Development	$6.575M	$19.35M	$3.750M
YoY Change	75.33%	16.41%	-19.08%
% of Gross Profit	3478.84%		729.57%
Depreciation & Amortization	$3.162M	$2.900M	$3.720M
YoY Change	-15.0%	0.0%	-70.16%
% of Gross Profit	1673.02%		723.74%
Operating Expenses	$15.87M	$61.76M	$14.23M
YoY Change	11.55%	5.75%	-14.82%
Operating Profit	-$15.68M	-$64.62M	-$13.72M
YoY Change	14.36%	7.0%	-49.01%
Interest Expense	$44.00K	$370.0K	-$148.0K
YoY Change	-129.73%	1847.37%	-92.49%
% of Operating Profit
Other Income/Expense, Net	-$12.00K	$2.382M	-$65.00K
YoY Change	-81.54%	-642.6%	103.13%
Pretax Income	-$15.65M	-$62.24M	-$13.92M
YoY Change	12.43%	2.32%	-2.7%
Income Tax	$229.0K	$225.0K	-$130.0K
% Of Pretax Income
Net Earnings	-$15.88M	-$62.46M	-$13.79M
YoY Change	15.15%	5.31%	0.43%
Net Earnings / Revenue	-641.4%	-758.77%	-1245.8%
Basic Earnings Per Share		-$0.28
Diluted Earnings Per Share	-$67.60K	-$275.2K	-$132.6K
COMMON SHARES
Basic Shares Outstanding	234.4M	227.0M	99.91M
Diluted Shares Outstanding

Balance Sheet

Concept	2021 Q4	2021	2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$98.39M	$98.39M	$16.36M
YoY Change	501.3%	501.3%	70.48%
Cash & Equivalents	$18.13M	$18.13M	$16.36M
Short-Term Investments	$80.26M	$80.26M	$0.00
Other Short-Term Assets	$957.0K	$4.212M	$2.966M
YoY Change	-67.73%	16.0%	-58.13%
Inventory	$8.634M	$8.634M	$10.03M
Prepaid Expenses	$3.255M		$3.535M
Receivables	$749.0K	$749.0K	$1.115M
Other Receivables	$1.311M	$1.311M	$2.870M
Total Short-Term Assets	$113.3M	$113.3M	$34.01M
YoY Change	233.1%	233.1%	21.67%
LONG-TERM ASSETS
Property, Plant & Equipment	$10.97M	$16.32M	$10.34M
YoY Change	6.08%	41.39%	119.76%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$37.44M	$37.44M
YoY Change
Other Assets	$1.014M	$9.530M	$186.0K
YoY Change	445.16%	-8.68%	-92.53%
Total Long-Term Assets	$73.18M	$73.18M	$44.25M
YoY Change	65.39%	65.39%	-5.51%
TOTAL ASSETS
Total Short-Term Assets	$113.3M	$113.3M	$34.01M
Total Long-Term Assets	$73.18M	$73.18M	$44.25M
Total Assets	$186.5M	$186.5M	$78.26M
YoY Change	138.28%	138.28%	4.65%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.448M	$3.448M	$1.965M
YoY Change	75.47%	75.47%	-45.1%
Accrued Expenses	$5.176M	$5.859M	$5.615M
YoY Change	-7.82%	-7.01%	-34.35%
Deferred Revenue	$543.0K		$789.0K
YoY Change	-31.18%		-3.55%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$0.00	$0.00	$1.228M
YoY Change	-100.0%	-100.0%
Total Short-Term Liabilities	$9.850M	$9.850M	$10.28M
YoY Change	-4.21%	-4.21%	-21.04%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$1.587M
YoY Change	-100.0%	-100.0%
Other Long-Term Liabilities	$7.377M	$7.377M	$628.0K
YoY Change	1074.68%	53.08%	-55.24%
Total Long-Term Liabilities	$0.00	$7.377M	$2.215M
YoY Change	-100.0%	15.16%	57.88%
TOTAL LIABILITIES
Total Short-Term Liabilities	$9.850M	$9.850M	$10.28M
Total Long-Term Liabilities	$0.00	$7.377M	$2.215M
Total Liabilities	$17.23M	$17.23M	$16.69M
YoY Change	3.22%	3.22%	-13.28%
SHAREHOLDERS EQUITY
Retained Earnings	-$785.4M		-$722.9M
YoY Change	8.64%		8.94%
Common Stock	$954.9M		$781.5M
YoY Change	22.18%		8.47%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$169.2M	$169.2M	$61.57M
YoY Change
Total Liabilities & Shareholders Equity	$186.5M	$186.5M	$78.26M
YoY Change	138.28%	138.28%	4.65%

Cashflow Statement

Concept	2021 Q4	2021	2020 Q4
OPERATING ACTIVITIES
Net Income	-$15.88M	-$62.46M	-$13.79M
YoY Change	15.15%	5.31%	0.43%
Depreciation, Depletion And Amortization	$3.162M	$2.900M	$3.720M
YoY Change	-15.0%	0.0%	-70.16%
Cash From Operating Activities	-$13.17M	-$40.66M	-$12.77M
YoY Change	3.19%	-12.89%	-82.63%
INVESTING ACTIVITIES
Capital Expenditures	-$530.0K	$1.368M	$0.00
YoY Change		45500.0%	-100.0%
Acquisitions
YoY Change
Other Investing Activities	-$30.07M	-$118.3M	$0.00
YoY Change			-100.0%
Cash From Investing Activities	-$30.60M	-$119.7M	$0.00
YoY Change		3988833.33%	-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.564M	$161.7M	8.936M
YoY Change	-82.5%	202.99%	-259.32%
NET CHANGE
Cash From Operating Activities	-13.17M	-$40.66M	-12.77M
Cash From Investing Activities	-30.60M	-$119.7M	0.000
Cash From Financing Activities	1.564M	$161.7M	8.936M
Net Change In Cash	-42.21M	$1.754M	-3.829M
YoY Change	1002.27%	-74.81%	-66.55%
FREE CASH FLOW
Cash From Operating Activities	-$13.17M	-$40.66M	-$12.77M
Capital Expenditures	-$530.0K	$1.368M	$0.00
Free Cash Flow	-$12.64M	-$42.03M	-$12.77M
YoY Change	-0.96%	-9.96%	-82.52%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021	dei	Auditor Location AuditorLocation	Raleigh, North Carolina
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	750000000
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	750000000
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	235218552
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	235218552
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	116231072
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	116231072
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2021	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	0	USD
CY2020	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	0	USD
CY2019	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	0	USD
CY2019	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	0	USD
CY2021	asxc	Period Of Service Sale Arrangement PeriodOfServiceSaleArrangement	P5Y
CY2021	asxc	Period Of Service Sale Arrangement At Stated Service Price PeriodOfServiceSaleArrangementAtStatedServicePrice	P4Y
CY2021	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	pure
CY2020	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	0	USD
CY2019	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	0	USD
CY2021	us-gaap	Number Of Reporting Units NumberOfReportingUnits	1	pure
CY2020Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	18129000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	16363000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	80262000	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	0	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	749000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1115000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	8634000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	10034000	USD
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	3255000	USD
CY2020Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	3535000	USD
CY2021Q4	asxc	Employer Retention Tax Credit Receivable EmployerRetentionTaxCreditReceivable	1311000	USD
CY2020Q4	asxc	Employer Retention Tax Credit Receivable EmployerRetentionTaxCreditReceivable	0	USD
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	957000	USD
CY2020Q4	us-gaap	Other Assets Current OtherAssetsCurrent	2966000	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	113297000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	34013000	USD
CY2021Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	1154000	USD
CY2020Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	1166000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	37435000	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	0	USD
CY2021Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	7074000	USD
CY2020Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	8813000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10971000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10342000	USD
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	288000	USD
CY2020Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	307000	USD
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	0	USD
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	13395000	USD
CY2020	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	13064000	USD
CY2019	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	28014000	USD
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	19323000	USD
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	14137000	USD
CY2019	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	18758000	USD
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	11254000	USD
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	10801000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	5348000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1164000	USD
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1014000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	186000	USD
CY2021Q4	us-gaap	Assets Assets	186473000	USD
CY2020Q4	us-gaap	Assets Assets	78258000	USD
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3448000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1965000	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5176000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5615000	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	683000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	686000	USD
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	543000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	789000	USD
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	0	USD
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	1228000	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	9850000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	10283000	USD
CY2021Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	2371000	USD
CY2020Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	3936000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5006000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	628000	USD
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1587000	USD
CY2021Q4	asxc	Warrant Liability WarrantLiability	0	USD
CY2020Q4	asxc	Warrant Liability WarrantLiability	255000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	17227000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	16689000	USD
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	235000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	116000	USD
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	954649000	USD
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	781397000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-785374000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-722912000	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-264000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	2968000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	169246000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	61569000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	186473000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	78258000	USD
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8232000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3175000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8531000	USD
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	11096000	USD
CY2020	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	5166000	USD
CY2019	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	20731000	USD
CY2021	us-gaap	Gross Profit GrossProfit	-2864000	USD
CY2020	us-gaap	Gross Profit GrossProfit	-1991000	USD
CY2019	us-gaap	Gross Profit GrossProfit	-12200000	USD
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	19348000	USD
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	16621000	USD
CY2019	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	22468000	USD
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	10301000	USD
CY2020	us-gaap	Operating Expenses OperatingExpenses	58398000	USD
CY2021	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-1565000	USD
CY2020	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	2924000	USD
CY2019	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-9553000	USD
CY2021	asxc	Restructuring And Other Charges RestructuringAndOtherCharges	0	USD
CY2020	asxc	Restructuring And Other Charges RestructuringAndOtherCharges	851000	USD
CY2019	asxc	Restructuring And Other Charges RestructuringAndOtherCharges	1374000	USD
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2020	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2019	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	78969000	USD
CY2021	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	USD
CY2020	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	USD
CY2019	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	7912000	USD
CY2021	us-gaap	Operating Expenses OperatingExpenses	61755000	USD
CY2019	us-gaap	Operating Expenses OperatingExpenses	142375000	USD
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-64619000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-60389000	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	-154575000	USD
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	2847000	USD
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2019	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1006000	USD
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	1981000	USD
CY2020	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	336000	USD
CY2019	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-2248000	USD
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	590000	USD
CY2020	us-gaap	Investment Income Interest InvestmentIncomeInterest	35000	USD
CY2019	us-gaap	Investment Income Interest InvestmentIncomeInterest	582000	USD
CY2021	us-gaap	Interest Expense InterestExpense	370000	USD
CY2020	us-gaap	Interest Expense InterestExpense	19000	USD
CY2019	us-gaap	Interest Expense InterestExpense	3607000	USD
CY2021	asxc	Other Income Employer Retention Tax Credit OtherIncomeEmployerRetentionTaxCredit	1311000	USD
CY2020	asxc	Other Income Employer Retention Tax Credit OtherIncomeEmployerRetentionTaxCredit	0	USD
CY2019	asxc	Other Income Employer Retention Tax Credit OtherIncomeEmployerRetentionTaxCredit	0	USD
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-15000	USD
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-119000	USD
CY2019	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-967000	USD
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2382000	USD
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-439000	USD
CY2019	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2750000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-62237000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-60828000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-157325000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	225000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1516000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3124000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-62462000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-59312000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-154201000	USD
CY2021	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	-0	USD
CY2020	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	412000	USD
CY2019	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	-0	USD
CY2021	us-gaap	Convertible Preferred Stock Converted To Other Securities ConvertiblePreferredStockConvertedToOtherSecurities	-0	USD
CY2020	us-gaap	Convertible Preferred Stock Converted To Other Securities ConvertiblePreferredStockConvertedToOtherSecurities	299000	USD
CY2019	us-gaap	Convertible Preferred Stock Converted To Other Securities ConvertiblePreferredStockConvertedToOtherSecurities	-0	USD
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-62462000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-60023000	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-154201000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-62462000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-59312000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-154201000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-2985000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	4338000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-2708000	USD
CY2021	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-247000	USD
CY2020	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0	USD
CY2019	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0	USD
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-65694000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-54974000	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-156909000	USD
CY2021	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.28
CY2020	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.85
CY2019	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-8.69
CY2021	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	226960000
CY2020	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	70809000
CY2019	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	17737000
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	168521000	USD
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	11508000	USD
CY2019	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	25777000	USD
CY2019	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	6599000	USD
CY2019	asxc	Stock Issued During Period Value Stock Options And Warrants Exercised StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised	538000	USD
CY2019	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	USD
CY2019	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	499000	USD
CY2019	us-gaap	Treasury Stock Retired Cost Method Amount TreasuryStockRetiredCostMethodAmount	-0	USD
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-2708000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-154201000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	55535000	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	7911000	USD
CY2020	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	33846000	USD
CY2020	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	0	USD
CY2020	asxc	Stock Issued During Period Value Exchange Of Shares For Warrants StockIssuedDuringPeriodValueExchangeOfSharesForWarrants	2470000	USD
CY2020	asxc	Stock Issued During Period Value Stock Options And Warrants Exercised StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised	3340000	USD
CY2020	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	USD
CY2020	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	36000	USD
CY2020	us-gaap	Treasury Stock Retired Cost Method Amount TreasuryStockRetiredCostMethodAmount	-0	USD
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	4338000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-59312000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	61569000	USD
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	9429000	USD
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	131929000	USD
CY2021	asxc	Stock Issued During Period Value Stock Options And Warrants Exercised StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised	33075000	USD
CY2021	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	1000	USD
CY2021	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	1063000	USD
CY2021	us-gaap	Treasury Stock Retired Cost Method Amount TreasuryStockRetiredCostMethodAmount	-0	USD
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-3232000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-62462000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	169246000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-62462000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-59312000	USD
CY2019	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-168000	USD
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-229000	USD
CY2020	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-105000	USD
CY2019	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-959000	USD
CY2019	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1006000	USD
CY2021	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	225000	USD
CY2020	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-1516000	USD
CY2019	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-3124000	USD
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	144000	USD
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-154201000	USD
CY2021	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	USD
CY2020	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	USD
CY2019	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	86881000	USD
CY2021	us-gaap	Depreciation Depreciation	2857000	USD
CY2020	us-gaap	Depreciation Depreciation	2898000	USD
CY2019	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1634000	USD
CY2021	asxc	Increase Decrease In Inventory Reserve IncreaseDecreaseInInventoryReserve	492000	USD
CY2019	us-gaap	Depreciation Depreciation	2166000	USD
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	11254000	USD
CY2020	asxc	Increase Decrease In Inventory Reserve IncreaseDecreaseInInventoryReserve	3034000	USD
CY2019	asxc	Increase Decrease In Inventory Reserve IncreaseDecreaseInInventoryReserve	-8931000	USD
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	1981000	USD
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	10801000	USD
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	10301000	USD
CY2021	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	0	USD
CY2020	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	0	USD
CY2019	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1513000	USD
CY2020	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	336000	USD
CY2021	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-409000	USD
CY2020	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-0	USD
CY2019	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	327000	USD
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	9429000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	7911000	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	11508000	USD
CY2021	asxc	Business Combination Interest Expense On Deferred Consideration BusinessCombinationInterestExpenseOnDeferredConsideration	0	USD
CY2020	asxc	Business Combination Interest Expense On Deferred Consideration BusinessCombinationInterestExpenseOnDeferredConsideration	0	USD
CY2019	asxc	Business Combination Interest Expense On Deferred Consideration BusinessCombinationInterestExpenseOnDeferredConsideration	756000	USD
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	2847000	USD
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-0	USD
CY2019	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-2248000	USD
CY2021	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-1565000	USD
CY2020	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	2924000	USD
CY2019	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-9553000	USD
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-174000	USD
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	447000	USD
CY2019	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-6083000	USD
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	611000	USD
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	4164000	USD
CY2019	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	16404000	USD
CY2021	asxc	Increase Decrease In Operating Lease Right Of Use Assets IncreaseDecreaseInOperatingLeaseRightOfUseAssets	4254000	USD
CY2020	asxc	Increase Decrease In Operating Lease Right Of Use Assets IncreaseDecreaseInOperatingLeaseRightOfUseAssets	-1106000	USD
CY2019	asxc	Increase Decrease In Operating Lease Right Of Use Assets IncreaseDecreaseInOperatingLeaseRightOfUseAssets	-2271000	USD
CY2021	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-146000	USD
CY2020	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-824000	USD
CY2019	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-2541000	USD
CY2021	asxc	Increase Decrease In Tax Credit Receivable IncreaseDecreaseInTaxCreditReceivable	1311000	USD
CY2020	asxc	Increase Decrease In Tax Credit Receivable IncreaseDecreaseInTaxCreditReceivable	-0	USD
CY2019	asxc	Increase Decrease In Tax Credit Receivable IncreaseDecreaseInTaxCreditReceivable	-0	USD
CY2021	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-902000	USD
CY2020	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-366000	USD
CY2019	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	5441000	USD
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1614000	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1758000	USD
CY2019	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-668000	USD
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-475000	USD
CY2020	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-2219000	USD
CY2021	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	4452000	USD
CY2020	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-1203000	USD
CY2019	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-2515000	USD
CY2021	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	0	USD
CY2020	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-83000	USD
CY2019	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	2401000	USD
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-40659000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-46675000	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-73484000	USD
CY2021	asxc	Proceeds From Sale Of Developed System Assets Net ProceedsFromSaleOfDevelopedSystemAssetsNet	0	USD
CY2020	asxc	Proceeds From Sale Of Developed System Assets Net ProceedsFromSaleOfDevelopedSystemAssetsNet	0	USD
CY2019	asxc	Proceeds From Sale Of Developed System Assets Net ProceedsFromSaleOfDevelopedSystemAssetsNet	15965000	USD
CY2021	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	122330000	USD
CY2020	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	-0	USD
CY2019	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	12883000	USD
CY2021	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	4030000	USD
CY2020	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	0	USD
CY2019	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	65000000	USD
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1368000	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3000	USD
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	437000	USD
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-119668000	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3000	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	67645000	USD
CY2021	asxc	Proceeds From Issuance Of Equity Net ProceedsFromIssuanceOfEquityNet	0	USD
CY2020	asxc	Proceeds From Issuance Of Equity Net ProceedsFromIssuanceOfEquityNet	13478000	USD
CY2019	asxc	Proceeds From Issuance Of Equity Net ProceedsFromIssuanceOfEquityNet	0	USD
CY2021	asxc	Proceeds From Issuance Of Common Stock Net ProceedsFromIssuanceOfCommonStockNet	131929000	USD
CY2020	asxc	Proceeds From Issuance Of Common Stock Net ProceedsFromIssuanceOfCommonStockNet	33847000	USD
CY2019	asxc	Proceeds From Issuance Of Common Stock Net ProceedsFromIssuanceOfCommonStockNet	25777000	USD
CY2021	asxc	Proceeds From Issuance Of Debt And Warrants Net Of Issuance Costs ProceedsFromIssuanceOfDebtAndWarrantsNetOfIssuanceCosts	0	USD
CY2020	asxc	Proceeds From Issuance Of Debt And Warrants Net Of Issuance Costs ProceedsFromIssuanceOfDebtAndWarrantsNetOfIssuanceCosts	2815000	USD
CY2019	asxc	Proceeds From Issuance Of Debt And Warrants Net Of Issuance Costs ProceedsFromIssuanceOfDebtAndWarrantsNetOfIssuanceCosts	0	USD
CY2021	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	-0	USD
CY2020	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	-0	USD
CY2019	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	31425000	USD
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1063000	USD
CY2020	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	36000	USD
CY2019	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	499000	USD
CY2021	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	-0	USD
CY2020	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	74000	USD
CY2019	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	-0	USD
CY2021	asxc	Proceeds From Stock Options And Warrants Exercised ProceedsFromStockOptionsAndWarrantsExercised	30839000	USD
CY2020	asxc	Proceeds From Stock Options And Warrants Exercised ProceedsFromStockOptionsAndWarrantsExercised	3340000	USD
CY2019	asxc	Proceeds From Stock Options And Warrants Exercised ProceedsFromStockOptionsAndWarrantsExercised	538000	USD
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	161705000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	53370000	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-5609000	USD
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	376000	USD
CY2020	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	270000	USD
CY2019	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	364000	USD
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1754000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	6962000	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-11084000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	17529000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10567000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	21651000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	19283000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	17529000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10567000	USD
CY2021	us-gaap	Interest Paid Net InterestPaidNet	0	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	0	USD
CY2019	us-gaap	Interest Paid Net InterestPaidNet	2187000	USD
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	170000	USD
CY2020	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	82000	USD
CY2019	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	75000	USD
CY2021	asxc	Transfer Of Inventory To Property And Equipment TransferOfInventoryToPropertyAndEquipment	3244000	USD
CY2020	asxc	Transfer Of Inventory To Property And Equipment TransferOfInventoryToPropertyAndEquipment	8113000	USD
CY2019	asxc	Transfer Of Inventory To Property And Equipment TransferOfInventoryToPropertyAndEquipment	486000	USD
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	5119000	USD
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	USD
CY2019	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	USD
CY2021	asxc	Reclassification Of Warrant Liability To Common Stock And Additional Paid In Capital ReclassificationOfWarrantLiabilityToCommonStockAndAdditionalPaidInCapital	2236000	USD
CY2020	asxc	Reclassification Of Warrant Liability To Common Stock And Additional Paid In Capital ReclassificationOfWarrantLiabilityToCommonStockAndAdditionalPaidInCapital	0	USD
CY2019	asxc	Reclassification Of Warrant Liability To Common Stock And Additional Paid In Capital ReclassificationOfWarrantLiabilityToCommonStockAndAdditionalPaidInCapital	0	USD
CY2021	us-gaap	Stock Issued1 StockIssued1	0	USD
CY2020	us-gaap	Stock Issued1 StockIssued1	2470000	USD
CY2019	us-gaap	Stock Issued1 StockIssued1	0	USD
CY2021	asxc	Transfer Of In Process Research And Development To Intellectual Property TransferOfInProcessResearchAndDevelopmentToIntellectualProperty	0	USD
CY2020	asxc	Transfer Of In Process Research And Development To Intellectual Property TransferOfInProcessResearchAndDevelopmentToIntellectualProperty	2425000	USD
CY2019	asxc	Transfer Of In Process Research And Development To Intellectual Property TransferOfInProcessResearchAndDevelopmentToIntellectualProperty	0	USD
CY2021	asxc	Deemed Dividend Related To Beneficial Conversion Feature Of Preferred Stock DeemedDividendRelatedToBeneficialConversionFeatureOfPreferredStock	0	USD
CY2020	asxc	Deemed Dividend Related To Beneficial Conversion Feature Of Preferred Stock DeemedDividendRelatedToBeneficialConversionFeatureOfPreferredStock	412000	USD
CY2019	asxc	Deemed Dividend Related To Beneficial Conversion Feature Of Preferred Stock DeemedDividendRelatedToBeneficialConversionFeatureOfPreferredStock	0	USD
CY2021	asxc	Deemed Dividend Related To Conversion Of Preferred Stock Into Common Stock DeemedDividendRelatedToConversionOfPreferredStockIntoCommonStock	0	USD
CY2020	asxc	Deemed Dividend Related To Conversion Of Preferred Stock Into Common Stock DeemedDividendRelatedToConversionOfPreferredStockIntoCommonStock	299000	USD
CY2019	asxc	Deemed Dividend Related To Conversion Of Preferred Stock Into Common Stock DeemedDividendRelatedToConversionOfPreferredStockIntoCommonStock	0	USD
CY2021	asxc	Issuance Of Common Stock Value For Acquisitions IssuanceOfCommonStockValueForAcquisitions	0	USD
CY2020	asxc	Issuance Of Common Stock Value For Acquisitions IssuanceOfCommonStockValueForAcquisitions	0	USD
CY2019	asxc	Issuance Of Common Stock Value For Acquisitions IssuanceOfCommonStockValueForAcquisitions	6600000	USD
CY2021	asxc	Proceeds From Sale Of Assets Exchanged For Settlement Of Company Obligations ProceedsFromSaleOfAssetsExchangedForSettlementOfCompanyObligations	0	USD
CY2020	asxc	Proceeds From Sale Of Assets Exchanged For Settlement Of Company Obligations ProceedsFromSaleOfAssetsExchangedForSettlementOfCompanyObligations	0	USD
CY2019	asxc	Proceeds From Sale Of Assets Exchanged For Settlement Of Company Obligations ProceedsFromSaleOfAssetsExchangedForSettlementOfCompanyObligations	1000000	USD
CY2021	asxc	Transfer Of Property And Equipment To Inventories TransferOfPropertyAndEquipmentToInventories	0	USD
CY2020	asxc	Transfer Of Property And Equipment To Inventories TransferOfPropertyAndEquipmentToInventories	0	USD
CY2019	asxc	Transfer Of Property And Equipment To Inventories TransferOfPropertyAndEquipmentToInventories	323000	USD
CY2021	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	0	USD
CY2020	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	79000	USD
CY2019	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	0	USD
CY2021	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b>Reclassifications</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Certain amounts reported previously have been reclassified to conform to the current year presentation, with <em style="font: inherit;">no</em> effect on stockholders’ equity or net loss as previously reported. These reclassifications relate to the (gain) loss on extinguishment of debt which was historically included in interest expense on the consolidated statements of operations for the year ended <em style="font: inherit;"> December 31, 2019.</em></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-785400000	USD
CY2021Q4	asxc	Working Capital WorkingCapital	103400000	USD
CY2021	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	30600000	USD
CY2021Q4	asxc	Cash Cash Equivalents Shortterm And Longterm Investments Excluding Restricted Cash CashCashEquivalentsShorttermAndLongtermInvestmentsExcludingRestrictedCash	135800000	USD
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b>Use of Estimates</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant items subject to such estimates and assumptions include impairment considerations for long- term assets, fair value estimates related to contingent consideration, warrant liabilities, stock compensation expense, revenue recognition, accounts receivable reserves, short-term and long-term investments, excess and obsolete inventory reserves, inventory classification between current and non-current, measurement of lease liabilities and corresponding right-of-use (“ROU”) assets, and deferred tax asset valuation allowances.</p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"> </p>
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	1200000	USD
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	1200000	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	0	USD
CY2020	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	0	USD
CY2021	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b>Concentrations and Credit Risk</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The Company’s principal financial instruments subject to potential concentration of credit risk are cash and cash equivalents, and investments, including amounts held in money market funds, commercial paper, and corporate bonds. The Company places cash deposits with a federally insured financial institution. The Company maintains its cash at banks and financial institutions it considers to be of high credit quality; however, the Company’s domestic cash deposits <em style="font: inherit;"> may </em>at times exceed the Federal Deposit Insurance Corporation’s insured limit. Balances in excess of federally insured limitations <em style="font: inherit;"> may </em><em style="font: inherit;">not</em> be insured. The Company has <em style="font: inherit;">not</em> experienced losses on these accounts, and management believes that the Company is <em style="font: inherit;">not</em> exposed to significant risks on such accounts. Investments are stated at their estimated fair values, based on quoted market prices for the same or similar instruments. The counterparties to the agreements relating to the Company’s investments consist of various major corporations, financial institutions, and government agencies of high credit standing.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The Company’s accounts receivable are derived from sales and leases to customers located throughout the world. The Company evaluates its customers’ financial condition and, generally, requires <em style="font: inherit;">no</em> collateral from its customers. The Company provided reserves for potential credit losses and recorded $0.1 million, $0 million, and $1.6 million in bad debt charges during the years ended <em style="font: inherit;"> December 31, 2021, </em><em style="font: inherit;">2020</em> and <em style="font: inherit;">2019,</em> respectively. The Company had <span style="-sec-ix-hidden:c81127448">three</span> customers who constituted 61% of the Company’s net accounts receivable as of <em style="font: inherit;"> December 31, 2021. </em>The Company had <span style="-sec-ix-hidden:c81127450">seven</span> customers who constituted 68% of the Company’s net accounts receivable at <em style="font: inherit;"> December 31, 2020. </em>The Company had <span style="-sec-ix-hidden:c81127452">two</span> customers who accounted for 52% of revenue in <em style="font: inherit;">2021,</em> <span style="-sec-ix-hidden:c81127455">nine</span> customers who accounted for 55% of revenue in <em style="font: inherit;">2020,</em> and <span style="-sec-ix-hidden:c81127458">six</span> customers who accounted for 82% of revenue in <em style="font: inherit;">2019.</em> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"> </p>
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	100000	USD
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	USD
CY2019	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1600000	USD
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1700000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1800000	USD
CY2021	asxc	Other Income Employer Retention Tax Credit OtherIncomeEmployerRetentionTaxCredit	1300000	USD
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8232000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3175000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8531000	USD
CY2021	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	1300000	USD
CY2020	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	700000	USD
CY2019	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	0	USD
CY2021Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	3000000.0	USD
CY2020Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	3100000	USD
CY2019Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	3700000	USD
CY2021Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	100000	USD
CY2020Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	100000	USD
CY2021	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	600000	USD
CY2020	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	600000	USD
CY2019	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	1000000.0	USD
CY2021	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	1300000	USD
CY2020	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	700000	USD
CY2019	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	0	USD
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	9400000	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7900000	USD
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	11500000	USD
CY2021Q4	us-gaap	Cash Cash	8343000	USD
CY2020Q4	us-gaap	Cash Cash	6679000	USD
CY2021Q4	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	5287000	USD
CY2020Q4	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	9684000	USD
CY2021Q4	us-gaap	Commercial Paper At Carrying Value CommercialPaperAtCarryingValue	4499000	USD
CY2020Q4	us-gaap	Commercial Paper At Carrying Value CommercialPaperAtCarryingValue	0	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	18129000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	16363000	USD
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	1154000	USD
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	1166000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	19283000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	17529000	USD
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	1200000	USD
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	1200000	USD
CY2021Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	117944000	USD
CY2021Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	1000	USD
CY2021Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	248000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	117697000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	80262000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	37435000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	80336000	USD
CY2020	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	2900000	USD
CY2019	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-9600000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	80262000	USD
CY2021Q4	asxc	Debt Securities Availableforsale Amortized Cost Maturity Next One To Two Years DebtSecuritiesAvailableforsaleAmortizedCostMaturityNextOneToTwoYears	37608000	USD
CY2021Q4	asxc	Debt Securities Availableforsale Fair Value Maturity Next One To Two Years DebtSecuritiesAvailableforsaleFairValueMaturityNextOneToTwoYears	37435000	USD
CY2021Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	117944000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	117697000	USD
CY2021	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	0	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	18129000	USD
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	1154000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	80262000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	37435000	USD
CY2021Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	136980000	USD
CY2021Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	2371000	USD
CY2021Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	2371000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	16363000	USD
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	1166000	USD
CY2020Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	17529000	USD
CY2020Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	3936000	USD
CY2020Q4	asxc	Warrant Liability WarrantLiability	255000	USD
CY2020Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	4191000	USD
CY2021	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-1600000	USD
CY2017Q2	asxc	Number Of Units Sold NumberOfUnitsSold	24900000
CY2017Q2	asxc	Number Of Shares In Each Unit NumberOfSharesInEachUnit	0.077
CY2017Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	1.00
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	2000000.0	USD
CY2020	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	300000	USD
CY2019	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-2200000	USD
CY2021Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	2426000	USD
CY2020Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	2917000	USD
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1677000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1802000	USD
CY2021Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	749000	USD
CY2020Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	1115000	USD
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	100000	USD
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	USD
CY2019	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1600000	USD
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	10566000	USD
CY2021Q4	asxc	Inventory Finished Goods Valuation Allowance InventoryFinishedGoodsValuationAllowance	2987000	USD
CY2021Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	7579000	USD
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	10824000	USD
CY2021Q4	asxc	Inventory Raw Materials Valuation Allowance InventoryRawMaterialsValuationAllowance	2695000	USD
CY2021Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	8129000	USD
CY2021Q4	asxc	Inventory Current And Noncurrent Gross InventoryCurrentAndNoncurrentGross	21390000	USD
CY2021Q4	asxc	Inventory Valuation Reserves Current And Noncurrent InventoryValuationReservesCurrentAndNoncurrent	5682000	USD
CY2021Q4	asxc	Inventory Current And Noncurrent Net InventoryCurrentAndNoncurrentNet	15708000	USD
CY2021Q4	us-gaap	Inventory Gross InventoryGross	9931000	USD
CY2021Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	1297000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	8634000	USD
CY2021Q4	asxc	Inventory Noncurrent Gross InventoryNoncurrentGross	11459000	USD
CY2021Q4	asxc	Inventory Valuation Reserves Noncurrent InventoryValuationReservesNoncurrent	4385000	USD
CY2021Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	7074000	USD
CY2021Q4	asxc	Inventory Current And Noncurrent Gross InventoryCurrentAndNoncurrentGross	21390000	USD
CY2021Q4	asxc	Inventory Valuation Reserves Current And Noncurrent InventoryValuationReservesCurrentAndNoncurrent	5682000	USD
CY2021Q4	asxc	Inventory Current And Noncurrent Net InventoryCurrentAndNoncurrentNet	15708000	USD
CY2020Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	13858000	USD
CY2020Q4	asxc	Inventory Finished Goods Valuation Allowance InventoryFinishedGoodsValuationAllowance	3109000	USD
CY2020Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	10749000	USD
CY2020Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	11163000	USD
CY2020Q4	asxc	Inventory Raw Materials Valuation Allowance InventoryRawMaterialsValuationAllowance	3065000	USD
CY2020Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	8098000	USD
CY2020Q4	asxc	Inventory Current And Noncurrent Gross InventoryCurrentAndNoncurrentGross	25021000	USD
CY2020Q4	asxc	Inventory Valuation Reserves Current And Noncurrent InventoryValuationReservesCurrentAndNoncurrent	6174000	USD
CY2020Q4	asxc	Inventory Current And Noncurrent Net InventoryCurrentAndNoncurrentNet	18847000	USD
CY2020Q4	us-gaap	Inventory Gross InventoryGross	11444000	USD
CY2020Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	1410000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	10034000	USD
CY2020Q4	asxc	Inventory Noncurrent Gross InventoryNoncurrentGross	13577000	USD
CY2020Q4	asxc	Inventory Valuation Reserves Noncurrent InventoryValuationReservesNoncurrent	4764000	USD
CY2020Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	8813000	USD
CY2020Q4	asxc	Inventory Current And Noncurrent Gross InventoryCurrentAndNoncurrentGross	25021000	USD
CY2020Q4	asxc	Inventory Valuation Reserves Current And Noncurrent InventoryValuationReservesCurrentAndNoncurrent	6174000	USD
CY2020Q4	asxc	Inventory Current And Noncurrent Net InventoryCurrentAndNoncurrentNet	18847000	USD
CY2019	us-gaap	Inventory Write Down InventoryWriteDown	7400000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	20660000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	24061000	USD
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	9689000	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	13719000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10971000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10342000	USD
CY2021	us-gaap	Depreciation Depreciation	2900000	USD
CY2020	us-gaap	Depreciation Depreciation	2900000	USD
CY2019	us-gaap	Depreciation Depreciation	2200000	USD
CY2016	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	61700000	USD
CY2018Q4	us-gaap	Goodwill Goodwill	80131000	USD
CY2019	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-1162000	USD
CY2019	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	78969000	USD
CY2019Q4	us-gaap	Goodwill Goodwill	0	USD
CY2019Q3	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	79000000.0	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	69238000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	59111000	USD
CY2021Q4	asxc	Finite Lived Intangible Assets Foreign Currency Translation Impact FiniteLivedIntangibleAssetsForeignCurrencyTranslationImpact	-235000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	9892000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	69238000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	51902000	USD
CY2020Q4	asxc	Finite Lived Intangible Assets Foreign Currency Translation Impact FiniteLivedIntangibleAssetsForeignCurrencyTranslationImpact	4931000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	22267000	USD
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2019	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	USD
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	USD
CY2019	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	USD
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	232000	USD
CY2020	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	169000	USD
CY2019	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	100000	USD
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	USD
CY2019	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	USD
CY2019	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-7000	USD
CY2020	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-1685000	USD
CY2019	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-3224000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	225000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1516000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3124000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-32094000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-34398000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-91935000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-30143000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-26430000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-65390000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-62237000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-60828000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-157325000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	2440000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	4253000	USD
CY2021Q4	asxc	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities Noncurrent DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilitiesNoncurrent	2423000	USD
CY2020Q4	asxc	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities Noncurrent DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilitiesNoncurrent	906000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	564000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	0	USD
CY2021Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	101000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	385000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	1109000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	2686000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	75237000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	63786000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	81874000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	72016000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	78294000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	67312000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	3580000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	4704000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	1176000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	1590000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	2116000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	2807000	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	3292000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	4397000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	288000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	307000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	1600000	USD
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	11000000.0	USD
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	100000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	1600000	USD
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1512000	USD
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1363000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	141000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	108000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	149000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	-0	USD
CY2020	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	1620000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	-0	USD
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	141000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1512000	USD
CY2021Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	USD
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-13070000	USD
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2020	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-12774000	USD
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2019	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-33038000	USD
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-2205000	USD
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.035	pure
CY2020	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-1768000	USD
CY2020	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.029	pure
CY2019	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-4778000	USD
CY2019	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.030	pure
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	-440000	USD
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.007	pure
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	719000	USD
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.012	pure
CY2019	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	709000	USD
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.005	pure
CY2021	asxc	Effective Income Tax Rate Reconciliation Change In Fair Market Value Of Contingent Consideration Amount EffectiveIncomeTaxRateReconciliationChangeInFairMarketValueOfContingentConsiderationAmount	-397000	USD
CY2021	asxc	Effective Income Tax Rate Reconciliation Change In Fair Market Value Of Contingent Consideration Percent EffectiveIncomeTaxRateReconciliationChangeInFairMarketValueOfContingentConsiderationPercent	0.006	pure
CY2020	asxc	Effective Income Tax Rate Reconciliation Change In Fair Market Value Of Contingent Consideration Amount EffectiveIncomeTaxRateReconciliationChangeInFairMarketValueOfContingentConsiderationAmount	717000	USD
CY2020	asxc	Effective Income Tax Rate Reconciliation Change In Fair Market Value Of Contingent Consideration Percent EffectiveIncomeTaxRateReconciliationChangeInFairMarketValueOfContingentConsiderationPercent	-0.012	pure
CY2019	asxc	Effective Income Tax Rate Reconciliation Change In Fair Market Value Of Contingent Consideration Amount EffectiveIncomeTaxRateReconciliationChangeInFairMarketValueOfContingentConsiderationAmount	-2342000	USD
CY2019	asxc	Effective Income Tax Rate Reconciliation Change In Fair Market Value Of Contingent Consideration Percent EffectiveIncomeTaxRateReconciliationChangeInFairMarketValueOfContingentConsiderationPercent	0.015	pure
CY2021	asxc	Effective Income Tax Rate Reconciliation Warrant Remeasurement And Financing Costs Amount EffectiveIncomeTaxRateReconciliationWarrantRemeasurementAndFinancingCostsAmount	502000	USD
CY2021	asxc	Effective Income Tax Rate Reconciliation Warrant Remeasurement And Financing Costs Percent EffectiveIncomeTaxRateReconciliationWarrantRemeasurementAndFinancingCostsPercent	-0.008	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses	0	pure
CY2020	asxc	Effective Income Tax Rate Reconciliation Goodwill Impairment Losses Amount EffectiveIncomeTaxRateReconciliationGoodwillImpairmentLossesAmount	0	USD
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses	0	pure
CY2019	asxc	Effective Income Tax Rate Reconciliation Goodwill Impairment Losses Amount EffectiveIncomeTaxRateReconciliationGoodwillImpairmentLossesAmount	-6638000	USD
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses	0.042	pure
CY2020	asxc	Effective Income Tax Rate Reconciliation Warrant Remeasurement And Financing Costs Amount EffectiveIncomeTaxRateReconciliationWarrantRemeasurementAndFinancingCostsAmount	82000	USD
CY2020	asxc	Effective Income Tax Rate Reconciliation Warrant Remeasurement And Financing Costs Percent EffectiveIncomeTaxRateReconciliationWarrantRemeasurementAndFinancingCostsPercent	-0.001	pure
CY2019	asxc	Effective Income Tax Rate Reconciliation Warrant Remeasurement And Financing Costs Amount EffectiveIncomeTaxRateReconciliationWarrantRemeasurementAndFinancingCostsAmount	-551000	USD
CY2019	asxc	Effective Income Tax Rate Reconciliation Warrant Remeasurement And Financing Costs Percent EffectiveIncomeTaxRateReconciliationWarrantRemeasurementAndFinancingCostsPercent	0.004	pure
CY2021	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	705000	USD
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment	0.011	pure
CY2020	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	542000	USD
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment	0.009	pure
CY2019	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	743000	USD
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment	0.005	pure
CY2021	asxc	Effective Income Tax Rate Reconciliation Unrecognized Tax Benefits Amount EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefitsAmount	141000	USD
CY2021	asxc	Effective Income Tax Rate Reconciliation Unrecognized Tax Benefits Percent EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefitsPercent	-0.002	pure
CY2020	asxc	Effective Income Tax Rate Reconciliation Unrecognized Tax Benefits Amount EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefitsAmount	-1512000	USD
CY2020	asxc	Effective Income Tax Rate Reconciliation Unrecognized Tax Benefits Percent EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefitsPercent	0.025	pure
CY2019	asxc	Effective Income Tax Rate Reconciliation Unrecognized Tax Benefits Amount EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefitsAmount	149000	USD
CY2019	asxc	Effective Income Tax Rate Reconciliation Unrecognized Tax Benefits Percent EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefitsPercent	-0.001	pure
CY2021	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	1911000	USD
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.031	pure
CY2020	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	1589000	USD
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.026	pure
CY2019	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	2590000	USD
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.016	pure
CY2021	asxc	Effective Income Tax Rate Reconciliation Goodwill Impairment Losses Amount EffectiveIncomeTaxRateReconciliationGoodwillImpairmentLossesAmount	0	USD
CY2021	asxc	Effective Income Tax Rate Reconciliation Adjustment For382 Limitations EffectiveIncomeTaxRateReconciliationAdjustmentFor382Limitations	0	USD
CY2021	asxc	Effective Income Tax Rate Reconciliation Adjustment For382 Limitations Percent EffectiveIncomeTaxRateReconciliationAdjustmentFor382LimitationsPercent	0	pure
CY2020	asxc	Effective Income Tax Rate Reconciliation Adjustment For382 Limitations EffectiveIncomeTaxRateReconciliationAdjustmentFor382Limitations	67255000	USD
CY2020	asxc	Effective Income Tax Rate Reconciliation Adjustment For382 Limitations Percent EffectiveIncomeTaxRateReconciliationAdjustmentFor382LimitationsPercent	-1.106	pure
CY2019	asxc	Effective Income Tax Rate Reconciliation Adjustment For382 Limitations EffectiveIncomeTaxRateReconciliationAdjustmentFor382Limitations	0	USD
CY2019	asxc	Effective Income Tax Rate Reconciliation Adjustment For382 Limitations Percent EffectiveIncomeTaxRateReconciliationAdjustmentFor382LimitationsPercent	0.000	pure
CY2021	asxc	Effective Income Tax Rate Reconciliation Trueup To Stock Compensation Cancellations Amount EffectiveIncomeTaxRateReconciliationTrueupToStockCompensationCancellationsAmount	2832000	USD
CY2021	asxc	Effective Income Tax Rate Reconciliation Trueup To Stock Compensation Cancellations Percent EffectiveIncomeTaxRateReconciliationTrueupToStockCompensationCancellationsPercent	-0.046	pure
CY2020	asxc	Effective Income Tax Rate Reconciliation Trueup To Stock Compensation Cancellations Amount EffectiveIncomeTaxRateReconciliationTrueupToStockCompensationCancellationsAmount	0	USD
CY2020	asxc	Effective Income Tax Rate Reconciliation Trueup To Stock Compensation Cancellations Percent EffectiveIncomeTaxRateReconciliationTrueupToStockCompensationCancellationsPercent	0	pure
CY2019	asxc	Effective Income Tax Rate Reconciliation Trueup To Stock Compensation Cancellations Amount EffectiveIncomeTaxRateReconciliationTrueupToStockCompensationCancellationsAmount	0	USD
CY2019	asxc	Effective Income Tax Rate Reconciliation Trueup To Stock Compensation Cancellations Percent EffectiveIncomeTaxRateReconciliationTrueupToStockCompensationCancellationsPercent	0.000	pure
CY2021	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	731000	USD
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	-0.010	pure
CY2020	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	533000	USD
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	-0.009	pure
CY2019	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	-253000	USD
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.002	pure
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	10925000	USD
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.176	pure
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-55815000	USD
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.918	pure
CY2019	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	41771000	USD
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.266	pure
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	225000	USD
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.004	pure
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1516000	USD
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.025	pure
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3124000	USD
CY2019	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.020	pure
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	1800000	USD
CY2020	us-gaap	Operating Lease Cost OperatingLeaseCost	2000000.0	USD
CY2019	us-gaap	Operating Lease Cost OperatingLeaseCost	2100000	USD
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	1500000	USD
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	1500000	USD
CY2019	us-gaap	Operating Lease Payments OperatingLeasePayments	1700000	USD
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y9M18D
CY2020Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y9M18D
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.078	pure
CY2020Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.082	pure
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	994000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1008000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	918000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	920000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	854000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	3004000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	7698000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	2009000	USD
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	5689000	USD
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3682000	USD
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4541000	USD
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	177000	USD
CY2021Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	247000	USD
CY2021Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	128000	USD
CY2020Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	66000	USD
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	124000	USD
CY2020Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	147000	USD
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	503000	USD
CY2020Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	314000	USD
CY2021Q4	us-gaap	Deferred Rent Credit Current DeferredRentCreditCurrent	492000	USD
CY2020Q4	us-gaap	Deferred Rent Credit Current DeferredRentCreditCurrent	351000	USD
CY2021Q4	us-gaap	Interest And Dividends Payable Current InterestAndDividendsPayableCurrent	0	USD
CY2020Q4	us-gaap	Interest And Dividends Payable Current InterestAndDividendsPayableCurrent	19000	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5176000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5615000	USD
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	9400000	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7900000	USD
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	11500000	USD
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4361872
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	10.49
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y18D
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1490266
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	4.06
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	285391
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	8.10
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	610287
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	30.32
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	315800
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.67
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4640660
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.64
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y7M28D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1887155
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	11.50
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y4M24D
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	700000	USD
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	4498953
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	6.75
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P5Y7M24D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	1400000	USD
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1490266
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	3005964
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	623272
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.40
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.53
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	21.23
CY2021Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	4000000.0	USD
CY2021	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y6M
CY2017Q2	asxc	Number Of Units Sold NumberOfUnitsSold	24900000
CY2017Q2	asxc	Number Of Shares In Each Unit NumberOfSharesInEachUnit	0.077
CY2017Q2	asxc	Equity Offering Price Per Unit EquityOfferingPricePerUnit	1.00
CY2020	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	400000	USD
CY2019Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	1753523
CY2019Q4	asxc	Sharebased Compensation Arrangement By Sharebased Payment Award Reserved For Issuance Assumed Weighted Average Exercise Price SharebasedCompensationArrangementBySharebasedPaymentAwardReservedForIssuanceAssumedWeightedAverageExercisePrice	1.39
CY2019	asxc	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Reserved For Issuance Weighted Average Remaining Contractual Terms SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsReservedForIssuanceWeightedAverageRemainingContractualTerms	P2Y2M12D
CY2019Q4	asxc	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Reserved For Issuance Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsReservedForIssuanceWeightedAverageGrantDateFairValue	1.22
CY2020Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	644966
CY2020Q4	asxc	Sharebased Compensation Arrangement By Sharebased Payment Award Reserved For Issuance Assumed Weighted Average Exercise Price SharebasedCompensationArrangementBySharebasedPaymentAwardReservedForIssuanceAssumedWeightedAverageExercisePrice	0.35
CY2020	asxc	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Reserved For Issuance Weighted Average Remaining Contractual Terms SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsReservedForIssuanceWeightedAverageRemainingContractualTerms	P1Y3M18D
CY2020Q4	asxc	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Reserved For Issuance Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsReservedForIssuanceWeightedAverageGrantDateFairValue	0.45
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	46498909
CY2020	us-gaap	Payments For Restructuring PaymentsForRestructuring	1733000	USD
CY2019Q4	us-gaap	Restructuring Charges RestructuringCharges	8800000	USD
CY2019Q4	us-gaap	Restructuring Reserve RestructuringReserve	882000	USD
CY2020	us-gaap	Restructuring Charges RestructuringCharges	851000	USD
CY2020Q4	asxc	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equityinstruments Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityinstrumentsOutstandingWeightedAverageExercisePrice	0.71
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P2Y4M24D
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	0.20
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	45317101
CY2021	asxc	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisedWeightedAverageExercisePrice	0.68
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations	61508
CY2021	asxc	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expired Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpiredWeightedAverageExercisePrice	1.35
CY2020	us-gaap	Convertible Preferred Stock Converted To Other Securities ConvertiblePreferredStockConvertedToOtherSecurities	300000	USD
CY2021	asxc	Stock Issued During Period Shares Warrants Exercised StockIssuedDuringPeriodSharesWarrantsExercised	45317101
CY2021	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	30600000	USD
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	9599990
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	53819880
CY2019	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4346057
CY2020Q4	us-gaap	Restructuring Reserve RestructuringReserve	0	USD

Files In Submission

Name	View Source	Status
0001437749-22-004657-index-headers.html	Edgar Link	pending
0001437749-22-004657-index.html	Edgar Link	pending
0001437749-22-004657.txt	Edgar Link	pending
0001437749-22-004657-xbrl.zip	Edgar Link	pending
a1.jpg	Edgar Link	pending
asxc-20211231.xsd	Edgar Link	pending
asxc-20211231_cal.xml	Edgar Link	unprocessable
asxc-20211231_def.xml	Edgar Link	unprocessable
asxc-20211231_lab.xml	Edgar Link	unprocessable
asxc-20211231_pre.xml	Edgar Link	unprocessable
ex_337761.htm	Edgar Link	pending
ex_337762.htm	Edgar Link	pending
ex_337764.htm	Edgar Link	pending
ex_337765.htm	Edgar Link	pending
ex_337766.htm	Edgar Link	pending
ex_337876.htm	Edgar Link	pending
ex_338292.htm	Edgar Link	pending
ex_338293.htm	Edgar Link	pending
ex_338294.htm	Edgar Link	pending
ex_338295.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
logo.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
transe20211231_10k.htm	Edgar Link	pending
transe20211231_10k_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$TRXDW
Stock $trxdw

2021 Q4 Form 10-K Financial Statement

#000143774922004657 Filed on February 28, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TRXDW Stock $trxdw

2021 Q4 Form 10-K Financial Statement

#000143774922004657 Filed on February 28, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TRXDW
Stock $trxdw